JeffreyLiebermanMD

PubMed

• Is schizophrenia neurodevelopmental, neurodegenerative or something else: A reply to Murray et al. (2022).
  William S Stone, Michael R Phillips, Lawrence H Yang, Lawrence S Kegeles, Jeffrey A Lieberman> ;Schizophrenia Research. 2023 Nov 1
• Illness Phase as a Key Assessment and Intervention Window for Psychosis.
  Christian G Kohler, Daniel H Wolf, Anissa Abi-Dargham, Alan Anticevic, Youngsun T Cho, Clara Fonteneau, Roberto Gil, Ragy R Girgis, David L Gray, Jack Grinband, Jonath...> ;Biological Psychiatry Global Open Science. 2023 Jul 1
• 2 citations
  Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study.
  Kazunari Yoshida, Victoria S Marshe, Samar S M Elsheikh, Malgorzata Maciukiewicz, Arun K Tiwari, Eva J Brandl, Jeffrey A Lieberman, Herbert Y Meltzer, James L Kennedy,...> ;The Pharmacogenomics Journal. 2023 Sep 1
• Increased parietal and occipital lobe gyrification predicts conversion to syndromal psychosis in a clinical high-risk cohort.
  Rakshathi Basavaraju, Jeanelle France, Hannah C Sigmon, Ragy R Girgis, Gary Brucato, Jeffrey A Lieberman, Scott A Small, Frank A Provenzano> ;Schizophrenia Research. 2023 May 1
• Victimology of Mass Shootings and Mass Murders Not Involving Firearms.
  Hannah M Hesson, Eileen A Shea, Paul S Appelbaum, Gabriella Dishy, Carol Cohen-Romano, Leda Kennedy, Melissa Bornico, Kathryn Lee, Tyler Pia, Faizan Syed, Alexandra Vi...> ;Violence and Victims. 2023 Feb 1
• 3 citations
  Mass murders involving firearms and other methods in school, college, and university settings: Findings from the Columbia Mass Murder Database.
  Ragy R Girgis, Russell Tyler Rogers, Hannah Hesson, Jeffrey A Lieberman, Paul S Appelbaum, Gary Brucato> ;Journal of Forensic Sciences. 2023 Jan 1
• 5 citations
  The neurobiology of duration of untreated psychosis: a comprehensive review.
  Anthony W Zoghbi, Jeffrey A Lieberman, Ragy R Girgis> ;Molecular Psychiatry. 2023 Jan 1
• 32 citations
  Neurodegenerative model of schizophrenia: Growing evidence to support a revisit.
  William S Stone, Michael R Phillips, Lawrence H Yang, Lawrence S Kegeles, Ezra S Susser, Jeffrey A Lieberman> ;Schizophrenia Research. 2022 May 1
• 3 citations
  How should we diagnose schizophrenia: Don't throw the baby out with the bath water.
  Michael B First, Jeffrey A Lieberman> ;Schizophrenia Research. 2022 Apr 1
• 716 citations
  Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
  Trubetskoy, V., Pardiñas, A., Qi, T., Panagiotaropoulou, G., Awasthi, S., Bigdeli, T., Bryois, J., Chen, C., Dennison, C., Hall, L., Lam, M., Watanabe, K., Frei, O., G...> ;Nature. 2022 Apr 1
• 24 citations
  The Rapid Rise in Investment in Psychedelics-Cart Before the Horse.
  Joshua Phelps, Ravi N Shah, Jeffrey A Lieberman> ;JAMA Psychiatry. 2022 Mar 1
• 1 citations
  Hippocampal Glutamate and Positive Symptom Severity in Clinical High Risk for Psychosis.
  Rakshathi Basavaraju, Jia Guo, Scott A Small, Jeffrey A Lieberman, Ragy R Girgis, Frank A Provenzano> ;JAMA Psychiatry. 2022 Feb 1
• 23 citations
  High-impact rare genetic variants in severe schizophrenia.
  Anthony W Zoghbi, Ryan S Dhindsa, Terry E Goldberg, Aydan Mehralizade, Joshua E Motelow, Xinchen Wang, Anna Alkelai, Matthew B Harms, Jeffrey A Lieberman, Sander Markx...> ;Proceedings of the National Academy of Sciences of the United States of America. 2021 Dec 21
• 1 citations
  The neurobiology of auditory and visual perceptual abnormalities in a clinical high-risk for psychosis cohort: A pilot morphometric magnetic resonance imaging study.
  Ragy R. Girgis, Xinyang Feng, Gary Brucato, Hannah C. Sigmon, Jeffrey A. Lieberman, Frank A. Provenzano> ;Journal of Psychiatric Research. 2021 Oct 1
• 9 citations
  Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia
  Anissa Abi-Dargham, Jonathan A. Javitch, Mark Slifstein, Alan Anticevic, Monica E. Calkins, Youngsun T. Cho, Clara Fonteneau, Roberto Gil, Ragy R. Girgis, Raquel E. Gu...> ;Schizophrenia Bulletin. 2021 Aug 23
• 43 citations
  Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder
  Joshua T. Kantrowitz, Zhengchao Dong, Matthew S. Milak, Rain Rashid, Lawrence S. Kegeles, Daniel C. Javitt, Jeffrey A. Lieberman, J. John Mann> ;Translational Psychiatry. 2021 Aug 5
• 5 citations
  Back to the Future - The Therapeutic Potential of Psychedelic Drugs.
  Jeffrey A. Lieberman> ;The New England Journal of Medicine. 2021 Apr 14
• 1 citations
  An exploratory magnetic resonance imaging study of suicidal ideation in individuals at clinical high-risk for psychosis
  Ragy R. Girgis, Rakshathi Basavaraju, Melanie M. Wall, Gary Brucato, Jeffrey A. Lieberman, Frank A. Provenzano> ;Psychiatry Research. Neuroimaging. 2021 Apr 7
• 3 citations
  A historical review of placebo-controlled, relapse prevention trials in schizophrenia: The loss of clinical equipoise
  Ryan E. Lawrence, Paul S. Appelbaum, Jeffrey A. Lieberman> ;Schizophrenia Research. 2021 Mar 1
• 96 citations
  Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia.
  Stephen K. Brannan, Sharon Sawchak, Andrew C. Miller, Jeffrey A. Lieberman, Steven M. Paul, Alan Breier> ;The New England Journal of Medicine. 2021 Feb 25
• 12 citations
  Psychotic symptoms in mass shootings v. mass murders not involving firearms: findings from the Columbia mass murder database
  Gary Brucato, Paul S. Appelbaum, Hannah Hesson, Eileen Shea, Gabriella Dishy, Kathryn Lee, Tyler Pia, Faizan Syed, Alexandra Villalobos, Melanie M. Wall, Jeffrey A. Li...> ;Psychological Medicine. 2021 Feb 17
• 4 citations
  Recency and intensification of positive symptoms enhance prediction of conversion to syndromal psychosis in clinical high-risk patients.
  Gary Brucato, Michael B. First, Gabriella Dishy, Shana S. Samuel, Qing Xu, Melanie M. Wall, Scott A. Small, Michael D. Masucci, Jeffrey A. Lieberman, Ragy R. Girgis> ;Psychological Medicine. 2021 Jan 1
• 6 citations
  Anti-viral properties of antipsychotic medications in the time of COVID-19.
  Ragy R. Girgis, Jeffrey A. Lieberman> ;Psychiatry Research. 2021 Jan 1
• 8 citations
  An imaging-based risk calculator for prediction of conversion to psychosis in clinical high-risk individuals using glutamate 1H MRS.
  Lawrence S. Kegeles, Adam Ciarleglio, Pablo León-Ortiz, Francisco Reyes-Madrigal, Jeffrey A. Lieberman, Gary Brucato, Ragy R. Girgis, Camilo de la Fuente-Sandoval> ;Schizophrenia Research. 2020 Dec 1
• 6 citations
  Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [11C]-(+)-PHNO PET with methylphenidate challenge study.
  Ragy R. Girgis, Mark Slifstein, Gary Brucato, Lawrence S. Kegeles, Tiziano Colibazzi, Jeffrey A. Lieberman, Anissa Abi-Dargham> ;Molecular Psychiatry. 2021 Jun 1
• Join now to see all

Journal Articles

• A Multicenter Study of Ketamine Effects on Functional Connectivity: Large Scale Network Relationships, Hubs and Symptom Mechanisms  
  Ragy R Girgis, Richard J Maddock, John D Ragland, Daniel C Javitt, Cameron S Carter, Joshua T Kantrowitz, Jeffrey Lieberman, John H Krystal, Lawrence S Kegeles, Willia..., ScienceDirect
• Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci  
  Andreassen OA, Harbo HF, Wang Y, Thompson WK, Schork AJ, Mattingsdal M, Zuber V, Bettella F, Ripke S, Kelsoe JR, Kendler KS, O'Donovan MC, Sklar P; The Psychiatric Gen..., Mol Psychiatry, 1/1/2014
• Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain  
  Brandl EJ, Lieberman JA, et al, Pharmacogenomics, 1/1/2014
• Investigation of melancortico system gene variants in antipsychotic-induced weight gain  
  Chowdhury NI, Souza RP, Tiwari AK, Brandl EJ, Sicard M, Meltzer HY, Lieberman JA, Kennedy JL, Muller DJ, World J Biol Psychiatry, 1/1/2014
• Young brains on drugs  
  DuPont RF, Lieberman JA, Science, 1/1/2014
• Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain  
  Gagliano SA, Tiwari AK, Freeman N, Lieberman JA, Meltzer HY, Kennedy JL, Knight J, Muller DJ, Hum Psychopharmacol, 1/1/2014
• A Hypothesis Driven Association Study of 28 Nuclear-Encoded Mitochondrial Genes With Antipsychotic-Induced Weight Gain in Schizophrenia  
  Goncalves VF, Zai CC, Tiwari AK, Brandl EJ, Derkach A, Meltzer HY, Lieberman JA, Muller DJ, Sun L, Kennedy JL, Neuropsychopharmacology, 1/1/2014
• Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbances  
  Kao AC, Rojnic Kuzman M, Tiwari AK, Zivkovic MV, Chowdhury NI, Medved V, Kekin I, Zai CC, Lieberman JA, Meltzer HY, Bozina T, Bozina N, Kennedy JL, Sertic J, Muller DJ, J psychiatry Res, 1/1/2014
• Imaging glutamate in schizophrenia: review of findings and implications for drug discovery  
  Poels EM, Kegeles LS, Kantrowitz JT, Slifstein M, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR, Mol Psychiatry, 1/1/2014
• Glutamatergic abnormalities in schizophrenia: a review of proton MRG findings  
  Poels EM, Kegeles LS, Kantrowitz JT, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR, Schizophr Res, 1/1/2014
• Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study  
  Shing EC, Tiwari AK, Brandl EJ, Zai CC, Lieberman JA, Meltzer HY, Kennedy JL, Muller DJ, Neuropsychobiology, 1/1/2014
• Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors  
  Andreassen OA, Djurovic S, Thompson WK, Schork AJ, Kendler KS, O'Donovan MC, Rujescu D, Werge T, van de Bunt M, Morris AP, McCarthy MI; International Consortium for Bl..., Am J Hum Gent, 1/1/2013
• Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain  
  Brandl EJ, Tiwari AK, Lett TA, Shaikh SA, Lieberman JA, Meltzer HY, Kennedy JL, Muller DJ, Human Psychopharmacol, 1/1/2013
• Anatomical abnormalities in gray and white matter of the cortical surface in persons with schizophrenia  
  Colibazzi T, Wexler B, Bansal R, Hao X, Liu J, Sanchez-Peña J, Corcoran, C, Lieberman JA, Peterson BS, PLoS One, 1/1/2013
• Deep resequencing and association analysis of schizophrenia candidate genes  
  Crowley JJ, Hilliard CE, Kim Y, Morgan MB, Lewis LR, Muzny DM, Hawes AC, Sabo A, Wheeler DA, Lieberman JA, Sullivan PF, Gibbs RA, Mol Psychiatry, 1/1/2013
• Getting the facts straight about gun violence and mental illness: putting compassion before fear  
  Fisher CE, Lieberman JA, Ann Intern Med, 1/1/2013
• Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder  
  Jarskog LF, Hamer RM, Catellier DJ, Stewart DD, Lavange L, Ray N, Golden LH, Lieberman JA, Stroup TS, METS Investigators, Am J Psychiatry, 1/1/2013
• Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs  
  Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, Andreassen OA, Anjorin A, A..., Nat Genet, 1/1/2013
• Response to the presidential address  
  Lieberman JA, Am J Psychiatry, 1/1/2013
• A randomized exploratory trial of an alpha-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia  
  Lieberman JA, Dunbar G, Segreti AC, Girgis RR, Seoane F, Beaver JS, Duan N, Hosford DA, Neuropsychopharmacology, 1/1/2013
• Localized differences in caudate and hippocampal shape are associated with schizophrenia but not antipsychotic type  
  McClure RK, Styner MA, Maltbie E, Lieberman JA, Gouttard S, Gerig G, Shi X, Zhu H, Psychiatry Res, 1/1/2013
• Genetic schizophrenia risk variants jointly modulate total brain and white matter volume  
  Terwisscha van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, Buizer-Voskamp JE, Boos HB, Cahn W, Hulshoff Pol HE, Ripke S, Ophoff RA, Kahn RS; Psychiatric Genome-w..., Biol Psychiatry, 1/1/2013
• Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia  
  Zai CC, Tiwari AK, Mazzoco M, de Luca V, Muller DJ, Shaikh SA, Lohoff FW, Freeman N, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Remington G, Kennedy JL, J psychiatry Res, 1/1/2013
• Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain  
  Brandl EJ, Frydrychowicz C, Tiwari AK, Lett TA, Kitzrow W, Büttner S, Erlich S, Meltzer HY, Lieberman JA, Kennedy JL, Muller DJ, Puls I, Prog Neuropsychopharmacol Biol Psychiatry, 1/1/2012
• Neurocognitive outcomes in the treatment of early-onset schizophrenia spectrum disorders study  
  Frazier JA, Guiliano AJ, Johnson JL, Yakutis L, Youngstrom EA, Breiger D, Sikich L, Findling RL, McClellan J, Hamer RM, Vitiello B, Lieberman JA, Hooper SR, J Am Acad Child Adolesc Psychiatry, 1/1/2012
• Join now to see all